Last 12 months
Inside the activity.
2 purchase rows · 107 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 26 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2023 Filed Aug 16, 2023 20:53 UTC |
MAHONEY DAVID LDirector
|
SaleCommon Stock | 15,000 | $30.95 | $464,200.50 |
DisclosureSEC source: 0000950170-23-043043 · ownership.xml · nonDerivative · entry 2 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Disclosed balance after: 1,222,078 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $30.83 to $31.14. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:53 UTC |
MAHONEY DAVID LDirector
|
SaleCommon Stock | 10,000 | $30.95 | $309,467.00 |
DisclosureSEC source: 0000950170-23-043043 · ownership.xml · nonDerivative · entry 1 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: Plan reported Ownership: Indirect · The Black Dog Private Foundation Disclosed balance after: 11,297 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $30.83 to $31.14. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 22:15 UTC |
Hunt HazelChief Scientific Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-23-040803 · ownership.xml · derivative · entry 3 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 22:15 UTC |
Hunt HazelChief Scientific Officer
|
Tax withholdingCommon Stock | 29,545 | $30.48 | $900,531.60 |
DisclosureSEC source: 0000950170-23-040803 · ownership.xml · nonDerivative · entry 2 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,601 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 22:15 UTC |
Hunt HazelChief Scientific Officer
|
Exercise / conversionCommon Stock | 50,000 | $3.02 | $151,000.00 |
DisclosureSEC source: 0000950170-23-040803 · ownership.xml · nonDerivative · entry 1 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 21:20 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 412 | $0.00 Strike: $8.27 | $0.00 |
DisclosureSEC source: 0000950170-23-040748 · ownership.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,571 Underlying: Common Stock · 412 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 21:20 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 412 | $8.27 | $3,407.24 |
DisclosureSEC source: 0000950170-23-040748 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 21:20 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 412 | $31.22 | $12,862.64 |
DisclosureSEC source: 0000950170-23-040748 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,720 F1 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $31.21 to $31.25. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 650 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · derivative · entry 6 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,350 Underlying: Common Stock · 650 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $6.55 | $0.00 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · derivative · entry 5 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 2,200 shares Expires 2025-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 650 | $30.16 | $19,600.75 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · nonDerivative · entry 4 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $30.14 | $66,308.00 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · nonDerivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 650 Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 650 | $5.86 | $3,809.00 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 19:07 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $6.55 | $14,410.00 |
DisclosureSEC source: 0000950170-23-040463 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:58 UTC |
BAKER G LEONARD JRDirector
|
GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007580 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:30 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0000950170-23-033534 · ownership.xml · derivative · entry 4 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:30 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 10,000 | $1.92 | $19,200.00 |
DisclosureSEC source: 0000950170-23-033534 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 17, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
OtherCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 16 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 68,634 F2 · kind: Transfer of shares without consideration to the Sean and Molly Maduck Living Trust. F3 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. Read SEC document |
| July 17, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 15 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,988 F1 · balance_after: Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 10:10 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-028453 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,029 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 8 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 8,061 F2 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 7 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 8,061 F2 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 8,061 F2 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 5 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,629 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,279 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,004 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,729 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 08, 2023 Filed Jun 13, 2023 01:15 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027554 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,454 F1 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:17 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000899243-23-014751 · doc4.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,571 Underlying: Common Stock · 10,000 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:17 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 10,000 | $23.60 | $236,000.00 |
DisclosureSEC source: 0000899243-23-014751 · doc4.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,132 F1 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.60 to $23.61. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:17 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 10,000 | $11.35 | $113,500.00 |
DisclosureSEC source: 0000899243-23-014751 · doc4.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:04 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 2,091 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-014516 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,179 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:04 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 2,091 | $22.97 | $48,030.27 |
DisclosureSEC source: 0000899243-23-014516 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,088 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:04 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
GrantCommon Stock | 1,411 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-014515 · doc4.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,132 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:04 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
GrantCommon Stock | 1,411 | $22.97 | $32,410.67 |
DisclosureSEC source: 0000899243-23-014515 · doc4.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,721 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:03 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 1,651 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-014514 · doc4.xml · nonDerivative · entry 2 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,408 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:03 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 1,651 | $22.97 | $37,923.47 |
DisclosureSEC source: 0000899243-23-014514 · doc4.xml · nonDerivative · entry 1 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,757 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:01 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-014510 · doc4.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,698 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:01 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 1,658 | $22.97 | $38,084.26 |
DisclosureSEC source: 0000899243-23-014510 · doc4.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,040 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 01, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
OtherCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 14 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 58,634 F2 · kind: Transfer of shares without consideration to the Sean and Molly Maduck Living Trust. F3 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. Read SEC document |
| June 01, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
GiftCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 13 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,988 F1 · balance_after: Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:25 UTC |
BAKER G LEONARD JRDirector
|
GrantStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001225208-23-006179 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthy anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
Alton Gregg HDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013739 · doc4.xml · derivative · entry 1 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
Park KimberlyDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013736 · doc4.xml · derivative · entry 1 Park Kimberly · CIK 0001788208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
Swisher Daniel N JRDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013735 · doc4.xml · derivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
WILSON JAMES NDirector
|
GrantStock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013738 · doc4.xml · derivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
MAHONEY DAVID LDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013734 · doc4.xml · derivative · entry 1 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
Cannon GillianDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013737 · doc4.xml · derivative · entry 1 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:00 UTC |
Murray Joshua M.Director
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000899243-23-013733 · doc4.xml · derivative · entry 1 Murray Joshua M. · CIK 0001867952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period. Read SEC document |
| May 10, 2023 Filed May 11, 2023 23:30 UTC |
Robb Gary CharlesChief Business Officer
|
SaleCommon Stock | 14,000 | $24.07 | $336,980.00 |
DisclosureSEC source: 0000899243-23-012758 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,997 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.99 to $24.16. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F3 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.